Literature DB >> 8364039

Ribonucleoprotein particle assembly and modification of U2 small nuclear RNA containing 5-fluorouridine.

J R Patton1.   

Abstract

An in vitro assembly/modification system was used to study the effect of 5-fluorouridine (5-FU) incorporation on the biosynthesis of the U2 small nuclear ribonucleoprotein particle (U2 snRNP). Labeled U2 RNAs were transcribed in vitro with 5-fluoro-UTP either partially supplementing or completely replacing UTP during synthesis. The resulting U2 RNAs have levels of 5-fluorouridine that range from 0 to 100% of the uridine content. When incubated in reactions containing extracts from HeLa cells, these 5-FU U2 RNAs are assembled into RNPs that are recognized by anti-Sm monoclonal antibody even when there is a complete replacement of uridine with 5-FU. However, when the in vitro assembled U2 snRNPs are subjected to buoyant density gradient centrifugation, the particles that contain 100% 5-FU are not resistant to salt dissociation. When the in vitro assembled U2 snRNPs were analyzed by velocity sedimentation gradient centrifugation, 5-FU incorporation correlated with a shift in the sedimentation rate of the particles. With 100% 5-FU incorporation, the peak of radioactivity shifted to approximately 15 S (control U2 RNA was at approximately 12 S). This peak from 5-FU U2 snRNPs was not resistant to dissociation on cesium sulfate gradients. The amount of pseudouridine (psi) found in the RNA from snRNP assembled in vitro on control and 5-FU-containing U2 RNAs was determined, and even at very low levels of 5-FU incorporation (5% replacement), the formation of psi was severely inhibited (36% of control). At higher levels of 5-FU incorporation, there was essentially no psi formed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364039     DOI: 10.1021/bi00085a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

Review 1.  Functions and mechanisms of spliceosomal small nuclear RNA pseudouridylation.

Authors:  Guowei Wu; Andrew T Yu; Athena Kantartzis; Yi-Tao Yu
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-02-18       Impact factor: 9.957

2.  Pseudouridylation (Psi) of U2 snRNA in S. cerevisiae is catalyzed by an RNA-independent mechanism.

Authors:  Xiaoju Ma; Xinliang Zhao; Yi-Tao Yu
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

Review 3.  RNA modifications: a mechanism that modulates gene expression.

Authors:  John Karijolich; Athena Kantartzis; Yi-Tao Yu
Journal:  Methods Mol Biol       Date:  2010

Review 4.  Spliceosomal snRNA modifications and their function.

Authors:  John Karijolich; Yi-Tao Yu
Journal:  RNA Biol       Date:  2010-03-14       Impact factor: 4.652

Review 5.  Insight into the mechanisms and functions of spliceosomal snRNA pseudouridylation.

Authors:  Hironori Adachi; Yi-Tao Yu
Journal:  World J Biol Chem       Date:  2014-11-26

Review 6.  Posttranscriptional RNA Pseudouridylation.

Authors:  Meemanage D De Zoysa; Yi-Tao Yu
Journal:  Enzymes       Date:  2017-03-11

Review 7.  5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.

Authors:  J L Grem
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

8.  Evaluation of the progression and treatment of experimental periodontitis in rats subjected to chemotherapy with 5-fluorouracil.

Authors:  Valdir Gouveia Garcia; Vivian Cristina Noronha Novaes; Juliano Milanezi de Almeida; Mariéllen Longo; Edilson Ervolino; Suely Regina Mogami Bomfim; Leticia Helena Theodoro
Journal:  Support Care Cancer       Date:  2014-12-18       Impact factor: 3.603

9.  In vitro splicing of pre-messenger RNA with extracts from 5-fluorouridine-treated cells.

Authors:  J R Patton
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

10.  Pseudouridine formation in U2 small nuclear RNA.

Authors:  J R Patton; M R Jacobson; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.